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Abstract 
Purpose: To investigate the therapeutic effect of Lianbeijuqin (LBJQ) decoction on periodontitis in rats 
in vivo and in vitro. 
Methods: High performance liquid chromatography (HPLC) was used to analyze the main constituents 
of LBJQ. Periodontitis in rats was induced in rats by ligation with bacteria-infected silk. Gingival index 
(GI) and attachment loss (AL) were evaluated. Additionally, the antibacterial activity of LBJQ against 
Porphyromonas gingivalis, Prevotella intermedius, Actinobacillus actinomycetemcomitans, 
Fusobacterium nucleatum, Streptococcus sanguis and Streptococcus mutans were evaluated using 
minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) values. 
Furthermore, the inhibitory effect of LBJQ on the release of TNF-α, IL-1 β and IL-6 was also determined.  
Results: HPLC revealed the presence of phellodendrine, baicalin, palmatine, berberine, baicalein, 
wogonin and obacunone in LBJQ. LBJQ decoction dose-dependently (200, 400 and 800 mg/kg) and 
significantly decreased GI and AL (p < 0.05) in the periodontitis model rats. It also exerted significant 
antibacterial effect against P. gingivalis (MIC, 0.64 mg/mL; MBC, 2.56 mg/mL), P. intermedius (MIC, 
0.32 mg/m; MBC, 2.56 mg/mL), A. actinomycetemcomitans (MIC, 1.28 mg/mL; MBC, 5.12 mg/mL), F. 
nucleatum (MIC, 0.16 mg/mL; MBC, 0.64 mg/mL), S. sanguis (MIC, 0.64 mg/mL; MBC, 5.12 mg/mL), 
and S. mutans (MIC, 0.16 mg/mL; MBC, 1.28 mg/mL). Moreover, LBJQ decoction dose-dependently 
and significantly decreased the release of TNF-α (p < 0.01), IL-1 β (p < 0.01) and IL-6 (p < 0.01) in LPS-
induced RAW 264.7 cells.  
Conclusion: LBJQ exerts therapeutic activity against periodontitis in rats via inhibition of the release of 
inflammatory cytokines and growth of oral anaerobic bacteria.   
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Periodontitis is a chronic oral inflammatory 
disorder that occurs in tooth-supporting tissues 
such as gingiva and radices dentis. It results in 
significant damage to surrounding tissue 
structures, leading to loss of teeth [1,2]. Besides 
tooth loss, periodontitis is associated with other 
discomforts such as gomphiasis, swelling and 
aching of gum, fever and bromopnea [3,4]. 
Current treatment and periodontal tissue 
regeneration strategies for periodontitis involve 
scaling, root planning and regenerative surgeries 
[5,6]. However, strategies for radical treatment of 
periodontitis are still limited [7].  
 
Lianbeijuqin (LBJQ) decoction is prepared from a 
Chinese herbal formula which consists of 7 
herbal medicines (Table 1). In Chinese traditional 
medicinal theory system, LBJQ is used for 
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clearing heat, drying dampness and for clinical 
treatment of chronic periodontitis. However, 
although LBJQ is a traditionally used Chinese 
formula for periodontitis treatment, its therapeutic 
effects and pharmacological mechanisms of 
action are still not clear.  
 
This study was carried out to evaluate the 
therapeutic effect of LBJQ in a rat model of 
periodontitis. In addition, the anti-bacterial effects 
of LBJQ on common oral pathogenic bacteria, 
and its inhibitory effects on the release of pro-
inflammatory cytokines in LPS-treated RAW 
264.7 cells were determined, with a view to 




Chemicals and reagents 
 
Dulbecco’s modified eagle medium (DMEM) and 
fetal bovine serum (FBS) were purchased from 
the Gibco Biotech. (Carlsbad, USA), 
lipopolysaccharide (LPS) and 3-(4, 5-
dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium 
bromide (MTT) were obtained from Sigma Co. 
(Shanghai, China). Tumor necrosis factor (TNF-
α), interleukin (IL)-β and IL-6 ELISA kits were 
purchased from the Wuhan CUSABIO Biotech. 
(Wuhan, China); standards (phellodendrine, 
ferulic acid, baicalin, palmatine, berberine, 
baicalein, wogonin and obacunone) were 




Sprague Dawley (SD) rats (260 ~ 280 g) were 
got from Shanghai Laboratory Animal Research 
Center (Shanghai, China). The rats were kept in 
a humidity/temperature-controlled room and 
allowed ad libitum access to food and water. The 
animal experimental protocols were performed 
according to the National Institute of Health 
Guide for the Care and Use of Laboratory 
Animals [8], and were approved by the Animal 
Care and Use Committee of the Linyi People’s 
Hospital (Linyi, China) (no. 1504A02). 
Cell culture 
 
The RAW264.7 cell line, a murine macrophage 
cell line, was purchased from the American Type 
Culture Collection (ATCC, Rockville, USA). 
RAW264.7 cells were cultured in DMEM 
containing 10 % FBS in a CO2 incubator (5 % 
CO2, 37 °C). 
 
Preparation of aqueous extracts of LBJQ 
 
Aqueous decocting is the primary method for 
preparation of LBJQ in folk medicine. The herbal 
contents of LBJQ were ground and extracted 6 
times with water. Each extraction lasted for 30. 
The pooled extract was filtered, and the clear 
filtrate was concentrated under in vacuum under 
50 °C with a rotary evaporator to yield the LBJQ 
aqueous extract (yield of LBJQ was 12.73 %). 
 
HPLC analysis of LBJQ 
 
The constituents of the extract were determined 
with HPLC using a gradient elution with a 
CAPCELL PAK MG II S5 C18 column (250 mm × 
4.6 mm, 5 μm) (Shiseido, Japan).The mobile 
phase consisted of acetonitrile (solvent A) and 
0.1 % phosphoric acid-water solution (solvent B, 
containing 0.02 M sodium phosphate 
monobasic), and the gradient program was 10 % 
A (0 - 10 min); 20 - 40 % A (10 - 30 min); 40 - 60 
% A (20 - 40 min); 40 - 60 min (40 – 60 % A); 
and 60 – 80 % A (40 - 60 min). The mobile flow 
rate was set at 1.0 mL/min, and the detection 
wavelength was at 215 nm. The column 
temperature and sample injection volume were 
30 °C and 10.0 μL, respectively. 
 
Determination of therapeutic effect of LBJQ 
on rat periodontitis  
 
Dental plaque bacteria were isolated from 
definite diagnosed periodontitis patients in the 
Linyi People’s Hospital, Linyi, China, and then 
diluted with normal saline. 
 
 
Table 1: Composition of LBJQ 
 
Name Plant origin Part Content (g) 
Coptidis Rhizoma Coptis chinensis Franch Roots 10 
Galla Chinensis Melaphis chinensis (Bell) Baker Insect gall  12 
Chrysanthemi Indici Flos Chrysanthemum indicum L. Flowers 15 
Scutellariae Radix Scutellaria baicalensis Georgi Roots 10 
Rhei Radix et Rhizoma Rheum palmatum L Roots 8 
Phellodendri Chinensis Cortex Phellodendrom chinense Schneid. Cortex 10 
Glycyrrhizae Radix et Rhizoma Glycyrrhiza uralensis Fisch. Roots 5 
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Subsequently, the diluted dental bacteria were 
inoculated in anaerobic blood agar plate with 
sterile 5-0 silks for 5 days at 37 °C. Thereafter, 
the dental bacteria-infected silks were ligatured 
around the maxillary first molar on the left side of 
rats under anesthesia (pentobarbital sodium, 45 
mg/kg, ip).The ligatures were removed 21 days 
after the ligature surgery. For normal (sham) rats, 
the same surgical protocol was given but with 
sterile 5-0 silks instead of dental bacteria 
infected 5-0 silks. 
 
The periodontitis model rats were divided 
randomly into 4 for groups (n = 10): control and 3 
LBJQ treatments groups (200, 400 and 800 
mg/kg). In addition, another set of 10 rats were 
treated as normal group. Rats in LBJQ 
treatments groups were orally administered 
LBJQ (200, 400 and 800 mg/kg, po), while rats in 
normal and control groups were orally given 
normal saline (10 mL/kg, po). At 4, 6, 8 and 10 
weeks after ligature surgery, the rats were 
anesthetized with pentobarbital sodium (45 
mg/kg, ip). Then gingival index (GI) and 
attachment loss (AL) were evaluated according 
to standard methods [9,10]. The GI was 
classified as follows: 0 (healthy gingiva; 1 (mild 
inflammation, i.e. mild change in gingiva color, 
and /or mild edema without bleeding); 2 
(moderate inflammation i.e. redness in gingiva, 
severe edema and bleeding) and 3 (severe 
inflammation, i.e., visibly red and swollen; 
ulcerous and bleeding). Four detecting points, 
namely papillae gingiva, buccal margin, palatine 
papillae and marginal gingiva of each 
experimental tooth were determined, and the 
mean score of the four points was taken as the 
GI value. Furthermore, a periodontal probe was 
used to detect the distance between the enamel-




The antibacterial activities of LBJQ against a 
number of oral pathogenic bacteria were 
determined. The oral bacteria were P. gingivalis 
(ATCC 33277), P. intermedius (ATCC25361), A. 
actinomycetemcomitans (ATCC29522), F. 
nucleatum (ATCC 23276), S. sanguis (ATCC 
6715) and S. mutans (ATCC 25175). The 
antibacterial effects of LBJQ were measured via 
evaluation of MICs and MBCs according to 
established methods [11, 12]. The final 
concentrations of LBJQ in bacterial culture 
medium were 10.24, 5.12, 2.56, 1.28, 0.64, 0.32, 
0.16, 0.08 and 0.04 mg/mL. The lowest LBJQ 
concentration which inhibited visible bacterial 
growth after 24 h incubation at 37 °C was 
considered as the MIC. In the evaluation of MBC, 
0.01mL bacterial culture medium after the MIC 
was inoculated on an agar plates for growth 
another 24 h at 37 °C, and MBC is the lowest 
concentration of LBJQ without visible bacterial 
growth. 
 
Effects of LBJQ on release of pro-
inflammatory cytokines in RAW 264.7 cells 
 
Cells (1.5×106) were seeded in a 48-well plate 
and cultured for 4 h. Then, the cells were 
incubated separately with different 
concentrations of LBJQ (200, 400 and 800 
μg/mL) and LPS (100 ng/mL) for another 8 h. 
Finally, the culture media were collected for 
assay of TNF-α, IL-1β and IL-6 with commercial 




Data are expressed as mean ± standard 
deviation (SD, n = 10). Differences in means 
between two groups were analyzed with two-
tailed Student’s t-test and were considered 






HPLC was used for the qualitative analysis of the 
constituents of LBJQ. As shown in Figure 1, 
seven (7) major compounds were identified 
based on their chromatographic behaviors 
relative to standards. These compounds were 
phellodendrine (1), baicalin (2), palmatine (3), 
berberine (4), baicalein (5), wogonin (6) and 
obacunone (7). 
 
Therapeutic effect of LBJQ  
 
Results showed that after the ligature surgery, GI 
was significantly increased at all the detecting 
time points relative to rats in normal group (p < 
0.01, Figure 2). However, after 4-week treatment, 
LBJQ (400 and 800 mg/kg) significantly 
decreased GI (p < 0.05, p < 0.01) in the 
periodontitis model rats, compared to rats in 
control group. Interestingly, after 6 weeks’ 
treatment (including at 6, 8 and 10 weeks), LBJQ 
(200, 400 and 800 mg/kg) significantly and dose-
dependently decreased GI (p < 0.01) when 
compared to control rats. 
 
In the periodontitis model rats, SAL was 
significantly increased when compared with 
normal rats (p < 0.01). However, the 4-week 
treatment with LBJQ (400 and 800 mg/kg) led to 
significant decreases in AL (p < 0.05), relative to 
control rats. At the end of 6-week treatment, 
LBJQ brought about significant and dose-
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dependent decreases in AL ( p < 0.01, p < 0.05) 





As shown in Table 2, LBJQ produced significant 
antibacterial activities against all the tested 
bacterial strains (P. gingivalis, P. intermedius, A. 
actinomycetemcomitans, F.nucleatum, S. 
sanguis and S. mutans), with MIC values below 2 
mg/mL (the MICs were 0.64, 0.32, 1.28, 0.16, 
0.64 and 0.16 mg/mL, respectively). The MBC 
values were less than 6 mg/mL (MICs were 2.56, 
2.56, 5.12, 0.64, 5.12 and 1.28 mg/mL, 
respectively). 
 
Effect of LBJQ on release of pro-
inflammatory cytokines 
 
After LPS treatment, there were significant 
increases in the release of pro-inflammatory 
cytokines (TNF-α, IL-1β and IL-6) from RAW 
264.7 cells (p < 0.01, Figure 4). However LBJQ 
exposure led to significant and dose-dependent 




Figure 1: HPLC analysis of the LBJQ. 1-7 represented the phellodendrine (1), baicalin (2), palmatine (3), 




Figure 2: Effect of LBJQ on GI of periodontitis rats. Data are represented as mean ± SD (n = 10); *p < 0.05, **p < 
0.01, compared to rats in control group 
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Figure 3: Effect of LBJQ on AL of periodontitis rats. Data are represented as mean ± SD (n = 10); *p < 0.05, **p 
< 0.01, compared to rats in control group 
 





Porphyromonas gingivalis  ATCC 33277 0.64 2.56 
Prevotella intermedius  ATCC 25361 0.32 2.56 
Actinobacillus actinomycetemcomitans  ATCC 29522 1.28 5.12 
Fusobacterium nucleatum  ATCC 23276 0.16 0.64 
Streptococcus sanguis  ATCC 6715 0.64 5.12 
Streptococcus mutans  ATCC 25175 0.16 1.28 
 
 
Figure 4: Effects of LBJQ on the releases of inflammatory cytokines induced by LPS in RAW 26.7 cells. Data are 
represented as mean ± SD (n = 10); *p < 0.05, **p < 0.01, compared to rats in control group. 
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Induction of periodontitis in rat model with dental 
bacteria-infected silk ligation is a standard 
experimental model for investigating therapeutic 
activities of candidate drugs against periodontitis 
[13,14]. The results of this study demonstrate for 
the first time, that LBJQ has potential therapeutic 
effect against experimental periodontitis in rats.   
 
In recent years, studies have revealed that the 
pathogenesis of periodontitis is closely related to 
dental plaque bacteria and their metabolic 
products which induce local inflammatory 
reactions in pre-disposed hosts [15]. Thus, the 
search for more effective agents for suppression 
of microbial invasion, control of inflammation and 
protection of periodontal tissue are the primary 
objectives of periodontitis treatment [4,17]. The 
results of the current research revealed that 
LBJQ, an age-old Chinese herbal medicine 
formula, could significantly inhibit the growth of 
common oral pathogenic bacteria such as P. 
gingivalis, P. intermedius, A. actinomycetem-
comitans, F. nucleatum, S. sanguis and S. 
mutans.  
 
Pro-inflammatory cytokines play important roles 
in the development of periodontitis. Inflammatory 
response leads to leukocyte infiltration, edema, 
vascular dilatation and release of excess 
inflammatory cytokines, resulting in detachment 
of connective tissue, formation of periodontal 
pocket and resorption of alveolar bone and 
ultimately tooth loss [18,19]. Previous 
investigations revealed that some early-response 
pro-inflammatory cytokines such as TNF-α, IL-6 
and IL-1β are released in response to external 
stimuli or tissue injury [20]. However, excessive 
levels of these pro-inflammatory cytokines 
activate inflammatory reaction cascades, thereby 
aggravating the inflammatory response that 
results in periodontitis [18,20]. It is also known 
that excess release of these pro-inflammatory 
cytokines induce damage to bone tissues of the 
teeth [2,21,22]. The results of this work 
demonstrate that LBJQ significantly decreased 
the releases of TNF-α, IL-1β and IL-6, which 
might be one of the potential mechanisms 




The findings of this study reveal that LBJQ 
possesses potential therapeutic effects against 
periodontitis in vivo and in vitro. The probable 
mechanism may be related to its inhibitory 
effects on release of inflammatory cytokines and 
its antibacterial activity against oral anaerobic 
bacteria. This finding may provide a basis for 
development of a new and effective drug from 
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